Are BMI and Negative Hormone Receptors Prognostic Factors in HER2+ Early-stage Breast Cancer?

CLINICAL BREAST CANCER

N/A

10.1016/j.clbc.2020.01.010

WOS:000558628300026

https://hdl.handle.net/11368/3040179

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85082772430

https://www.sciencedirect.com/science/article/pii/S1526820920300264?via=ihub

open access

license:copyright editore

license:creative commons

license uri:iris.pri02

license uri:http://creativecommons.org/licenses/by-nc-nd/4.0/

https://arts.units.it/request-item?handle=11368/3040179